C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available PRK Q1 2026 Earnings EPS Miss Weighs on Modest Revenue Growth Stock Holds Steady CTBI Q1 2026 Earnings Earnings Beat Driven by Strong Credit Quality and Operational Discipline FNLC Q1 2026 Earnings Modest Performance Amid Narrowing Margins Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat on Strong Operations Stock Holds Steady